Table 2 of Dunmire, Mol Vis 2011; 17:779-791.
Protein description | Biological process GO term | Cellular component GO term |
---|---|---|
Alpha-1D adrenoceptor (ADRA1D) | GO:0007165-Signal transduction | GO:0016021-Integral to membrane |
Beta-1 adrenergic receptor (ADRB1) | GO:0007165-Signal transduction | GO:0016021-Integral to membrane |
Ephrin receptor A2 (EPHA2) | GO:0007165-Signal transduction | GO:0016021-Integral to membrane |
Taste receptor type 2 (TAS2R5) | GO:0007165-Signal transduction | GO:0016021-Integral to membrane |
Nicotinic receptor alpha 5 subunit (CHRNA5) | GO:0007165-Signal transduction | GO:0016021-Integral to membrane |
Alpha-1A adrenoceptor (ADRA1A) | GO:0007165-Signal transduction | GO:0016021-Integral to membrane |
Toll-like receptor 8 (TLR8) | GO:0006955-Immune response | GO:0016021-Integral to membrane |
MHC class I antigen (HLA-B) | GO:0006955-Immune response | GO:0016021-Integral to membrane |
Lewis alpha-3-fucosyltransferase (FUT3) | GO:0043687-Post-translational protein modification | GO:0031090-Organelle membrane |
Cytochrome P450, 3A43 (CYP3A43) | GO:0055114-Oxidation reduction | GO:0031090-Organelle membrane |
Phosphoglycerate kinase 1 (PGK1) | GO:0043687-Post-translational protein modification | GO:0005737-Cytoplasm |
Cereblon (CRBN) | GO:0043687-Post-translational protein modification | GO:0005737-Cytoplasm |
Tyrosine kinase-2 (TYK2) | GO:0043687-Post-translational protein modification | GO:0005737-Cytoplasm |
Keratin 18 (CK18) | GO:0006915-Apoptosis | GO:0005737-Cytoplasm |
28kDa calbindin 1 (CALB1) | GO:0048167-Regulation of synaptic plasticity | GO:0005737-Cytoplasm |
Protein phosphatase 1, regulatory subunit 10 (PPP1R10) | GO:0006350-Transcription | GO:0005634-Nucleus |
C-C motif chemokine 5 (CCL5) | GO:0006954-Inflammatory response | GO:0005576-Extracellular region |
Complement factor 4 (C4) | GO:0006954-Inflammatory response | GO:0005576-Extracellular region |
Tissue factor pathway inhibitor (TFPI) | GO:0007596-Blood coagulation | GO:0005576-Extracellular region |